Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...

High cholesterol is one of the most common and manageable risk factors for heart disease. Millions of adults are prescribed cholesterol-lowering drugs to reduce low-density lipoprotein (LDL) ...

Statins are one of our most powerful tools in the war against high cholesterol, but there are several persistent myths about their safety ...

March 30 () - Merck's oral drug reduced bad cholesterol by up to ‌64.6% in a late-stage trial, ‌the drugmaker said on Monday, ...

Both statin and ezetimibe are commonly prescribed medicines to manage high cholesterol levels. Read on as a doctor explains ...

By Christy Santhosh March 30 (Reuters) - Drugmaker Merck said on Monday its oral drug met the main goal of meaningfully ...

New research indicates that the majority of side-effects commonly linked to statins are not, in fact, caused by the medication itself. A comprehensive study, published in The Lancet, examined data ...

New recommendations suggest that some people should start trying to lower their cholesterol as early as age 30.

The volume of evidence behind a therapy has become inversely correlated with public trust in it,” writes Vikas Patel.

Going gluten-free to beat IBS symptoms, choline for anxiety, and more health and wellness tips to start your week.

New guidelines say fish oil supplements don’t lower cholesterol or heart risk—and may even cause harm in some cases.